More on TNGX

- Summary
- Chart
- Profile
- Historical

Data

- Earnings (+8.6% Growth)
- Ratings (9.3 Score)

Upcoming Events

- Earnings (8/12/26)

News

- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks
More...

Tango Therapeutics, Inc (NQ:TNGX)
Delayed: 28.10 -0.92 (3.17%)
Prev. Close $29.02  
Open$28.19 
52 Wk High$ 
52 Wk Low$ 
Day High$28.69 
Day Low$27.92 
P/E N/A  
EPS$ 
Volume1,243,816 

Friends, Peers and Foes (?): ABBV, ONCY, TEVA, NUVL, PRAX (more...)

Jul 17, 2026 06:34 AM Tango Therapeutics Inc. (TNGX) PT Raised to $40 at Mizuho
Jul 15, 2026 03:01 AM JPMorgan Starts Tango Therapeutics Inc. (TNGX) at Overweight
Jul 2, 2026 07:24 PM Form 4 Tango Therapeutics, Inc. For: Jul 01 Filed by: Crystal Adam
Jun 29, 2026 04:06 AM Tango Therapeutics Inc. (TNGX) PT Raised to $46 at Canaccord
Jun 25, 2026 04:03 PM Jefferies Upgrades Tango Therapeutics Inc. (TNGX) to Buy
Jun 23, 2026 06:11 PM Form 4 Tango Therapeutics, Inc. For: Jun 19 Filed by: Azelby Robert
Jun 23, 2026 06:04 PM Form 3 Tango Therapeutics, Inc. For: Jun 19 Filed by: Azelby Robert
Jun 23, 2026 05:19 PM Form 8-K Tango Therapeutics, Inc. For: Jun 19
Jun 22, 2026 04:05 PM Tango Therapeutics adds Robert Azelby to its board of directors
Jun 22, 2026 04:05 PM Tango Therapeutics Appoints Robert Azelby to Board of Directors
View All Articles

Entities mentioned with TNGX

View All Entities